PSORIASIS TREATMENT

Advertisement
Dec 10 2025HEALTH

Red Light Shines Hope on Psoriasis Treatment

Psoriasis is a skin condition that causes red, itchy, and scaly patches. It happens when the immune system goes into overdrive. Scientists have been looking into new ways to treat it. One interesting approach is using red light from LEDs. This light has a wavelength of 660 nm. It might help calm dow

reading time less than a minute
Jul 02 2025HEALTH

How Risankizumab Helps People with Psoriasis

Psoriasis is a skin condition that can be quite tough to deal with. It causes red, scaly patches on the skin and can make life really hard for those who have it. Recently, a new drug called risankizumab has been approved to help people with moderate-to-severe plaque psoriasis. This drug works by tar

reading time less than a minute
May 19 2025HEALTH

The Power of Combination Therapy in Psoriasis Treatment

Psoriasis is a long-term skin condition that affects a significant number of people worldwide. Around 2-3% of the global population deals with this issue. Over the years, various treatments have been developed to manage and reduce the symptoms of psoriasis. These treatments have led to notable impro

reading time less than a minute
Apr 24 2025HEALTH

The Hidden Link Between Psoriasis and Obesity

Psoriasis and obesity often go hand in hand. These two long-term health issues share similar underlying problems. One key factor is a persistent, low-level inflammation that affects both body fat and skin. This link means that people with psoriasis who are also obese may face a tougher battle. Their

reading time less than a minute
Mar 22 2025HEALTH

Psoriasis Treatments: Risankizumab and Secukinumab Face Off

Psoriasis is a tough skin condition. It can be really hard to deal with. It can be mild or severe. It can be a real pain. There are two treatments that are quite popular in Italy. They are risankizumab and secukinumab. Both are known to be effective. They help a lot of people. But which one

reading time less than a minute
Jan 14 2025HEALTH

Skin Condition Spotlight: Psoriasis Treatment in Germany

Psoriasis, a long-term skin disorder causing red, scaly patches, is on the rise globally. However, not many studies have looked into how it's treated and the impact it has on healthcare in places like Germany. Let's dive into some real-world data to understand what's going on. In Germany, a specifi

reading time less than a minute
Dec 26 2024HEALTH

Psoriasis Treatment: Age and BMI Matter

Did you know that age and body mass index (BMI) could play a significant role in how well a psoriasis treatment works? A recent study looked into a medication called deucravacitinib, a type of drug that blocks certain proteins in the body. This study wanted to find out what factors might make some p

reading time less than a minute
Dec 10 2024SCIENCE

The mTOR Pathway's Role in Psoriasis: A Closer Look

Have you ever wondered how certain cells in our body go haywire and cause conditions like psoriasis? One key player in this puzzle is the mammalian target of rapamycin, or mTOR for short. This pathway is like the body's metabolic traffic cop, controlling how cells grow and divide. Recent research h

reading time less than a minute
Dec 10 2024HEALTH

Hidradenitis Suppurativa and Psoriasis: Can Anti-IL-17/23 Drugs Help?

Hidradenitis suppurativa (HS) and psoriasis are both long-term inflammatory conditions that share similar immune system pathways. Both diseases involve cytokines like tumor necrosis factor-alpha, interleukin (IL)-17, and IL-23. Currently, treatment choices for HS are limited, with only adalimumab an

reading time less than a minute